 |
市場調查報告書
商品編碼
1672739
免疫學市場按藥物類別、適應症、通路和地區分類Immunology Market, By Drug Class, By Disease Indication, By Distribution Channel, By Geography |
||||||
2025 年全球免疫學市場規模估計為 1,084.9 億美元，預計到 2032 年將達到 2,460.4 億美元，2025 年至 2032 年的複合年成長率為 12.4%。
| 報告範圍 | 報告詳細資訊 | ||
|---|---|---|---|
| 基準年 | 2024 | 2025 年市場規模 | 1084.9億美元 |
| 效能資料 | 2020-2024 | 預測期 | 2025-2032 |
| 預測期：2025 年至 2032 年複合年成長率 | 12.40％ | 2032 年金額預測 | 2460.4億美元 |
免疫學是一門研究免疫系統的學科，免疫系統可以保護身體免受細菌和病毒等外來入侵者的侵害。它涉及保護宿主免受感染和疾病的複雜細胞和分子機制。全球免疫學市場包括各種檢測、套件、儀器和軟體，用於疾病診斷、藥物開發和研究活動等各種目的。它面向醫院、研究機構、製藥和生物技術公司等最終用戶。由於慢性病的增加、對個人化醫療的日益關注以及生物標記和伴同性診斷的更廣泛應用，市場正在大幅成長。然而，不斷上升的測試成本和監管問題對市場進入者構成了挑戰。免疫測量技術的進步、生技藥品行業的成長以及穩定藥物的廣泛使用可能會在不久的將來推動免疫學市場的成長。
市場動態
全球免疫學市場的成長受到癌症、糖尿病和心血管疾病等慢性疾病日益流行的推動。根據世界衛生組織資料顯示，2020年慢性病將佔全球全部死亡人數的70%以上。此外，老年人口的增加也將成為市場成長的驅動力，因為上述疾病的風險會隨著老齡化的成長而增加。人們對精準醫療的日益關注推動了生物標記、伴同性診斷和免疫檢測測試在疾病管理中的開發和應用。預計這將在預測期內推動對免疫學相關產品的需求。然而，先進測試的高成本可能帶來重大挑戰，特別是對價格敏感的新興市場。此外，嚴格的產品核可監管程序可能會減緩參與企業進入市場的能力。增加研究活動，特別是在免疫腫瘤學和免疫治療領域，可以提供有利可圖的機會。檢測方法開發技術的不斷進步也可能擴大免疫學產品的用途。
研究的主要特點
- 本報告對全球免疫學市場進行了詳細分析，並給出了預測期（2025-2032 年）的市場規模（以十億美元計）和年複合成長率（CAGR%），假設 2024 年為基準年。
- 它還強調了各個領域的潛在商機並解釋了該市場的有吸引力的投資提案矩陣。
- 它還提供了對市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。
- 該報告根據公司亮點、產品系列、關鍵亮點、財務表現和策略等參數，概述了全球免疫學市場的主要企業。
- 本報告的見解將使負責人和企業經營團隊能夠就未來產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
- 全球免疫學市場報告迎合了該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
- 相關人員將透過全球免疫學市場分析中使用的各種策略矩陣更輕鬆地做出決策。
目錄
第1章 調查目的與前提條件
- 研究目標
- 先決條件
- 簡稱
第2章 市場展望
- 報告描述
- 市場定義和範圍
- 執行摘要
- 一致的機會圖 (COM)
第3章市場動態、法規與趨勢分析
- 市場動態
- 驅動程式
- 限制因素
- 機會
- 影響分析
- 市場趨勢
- 監管情景
- 收購和合作場景
- 資金籌措和投資
- PEST分析
- 波特的分析
第 4 章。
- 整體影響
- 政府舉措
- COVID-19 市場影響
5. 2020 年至 2032 年全球免疫學市場（按藥物類別分類）（十億美元）
- 介紹
- 單株抗體（mAb）
- 融合蛋白
- 免疫抑制劑
- 多株抗體（pAbs）
- 其他
6. 2020 年至 2032 年全球免疫學市場（按適應症分類）（十億美元）
- 介紹
- 類風濕性關節炎
- 乾癬性關節炎
- 斑塊型乾癬
- 僵直性脊椎炎
- 發炎性腸道疾病
- 預防器官排斥
- 其他
7. 2020-2032 年全球免疫學市場按分銷管道分類（十億美元）
- 介紹
- 醫院藥房
- 零售藥局
- 網路藥局
8. 2020 年至 2032 年全球免疫學市場（按地區分類）（十億美元）
- 介紹
- 北美洲
- 拉丁美洲
- 歐洲
- 亞太地區
- 中東
- 非洲
第9章 競爭格局
- 公司簡介
- AbbVie Inc.
- Johnson & Johnson
- Amgen Inc.
- F. Hoffmann-La Roche Ltd
- Pfizer Inc.
- Novartis International AG
- Bristol-Myers Squibb Company
- Merck &Co., Inc.
- AstraZeneca PLC
- Sanofi
- GlaxoSmithKline plc
- UCB SA
- Eli Lilly and Company
- Gilead Sciences Inc.
- Celgene Corporation
- Biogen Inc.
- Regeneron Pharmaceuticals Inc.
- Teva Pharmaceutical Industries Ltd.
第 10 章分析師建議
- 興衰
- 一致的機會地圖
第 11 章 參考文獻與調查方法
- 參考
- 調查方法
Global Immunology Market is estimated to be valued at USD 108.49 Bn in 2025 and is expected to reach USD 246.04 Bn by 2032, growing at a compound annual growth rate (CAGR) of 12.4% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 108.49 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 12.40% | 2032 Value Projection: | USD 246.04 Bn |
Immunology is the study of the immune system, which protects the body from foreign invaders like bacteria and viruses. It involves complex cellular and molecular mechanisms that defend the host from infection or disease. Global immunology market encompasses various assays, kits, instruments and software that are used for various purposes like disease diagnosis, drug development and research activities. It caters to end users like hospitals, research institutes, pharmaceutical and biotechnology companies. The market has witnessed significant growth due to increasing prevalence of chronic diseases, rising focus on personalized medicine and growing adoption of biomarkers and companion diagnostics. However, high costs of tests and regulatory issues can pose challenges to market players. The advancements in immunoassay technologies, growing biologics industry, and popularity of poised can drive the immunology market growth in the near future.
Market Dynamics:
Global immunology market growth is driven by increasing prevalence of chronic diseases like cancer, diabetes and cardiovascular disorders. According to the data from WHO, chronic diseases accounted for over 70% of all deaths globally in 2020. Growing geriatric population can also drive the market growth as age increases the risk of above-mentioned conditions. Rising focus on precision medicine has bolstered the development and adoption of biomarkers, companion diagnostics and immunoassay tests in disease management. This is expected to boost demand for immunology products over the forecast period. However, high costs associated with advanced tests can pose significant challenges, especially in price-sensitive developing markets. Stringent regulatory processes for new product approvals can also delay market entry for players. Rising research activities especially in the fields of cancer immunology and immunotherapy can present lucrative opportunities. Continuous technological advancements in assay development can also expand the applications of immunology products.
Key Features of the Study:
- This report provides in-depth analysis of the global immunology market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global immunology market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Abbott, Roche Diagnostics, Siemens Healthineers, Thermo Fisher Scientific Inc, Bio-Rad Laboratories Inc, Sysmex Corporation, Beckman Coulter Inc, Danaher Corporation.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- Global immunology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global immunology market.
Detailed Segmentation-
- By Drug Class
- Monoclonal Antibody (mAb)
- Fusion Proteins
- Immunosuppressants
- Polyclonal Antibody (pAb)
- Others
- By Disease Indication
- Rheumatoid Arthritis
- Psoriatic Arthritis
- Plaque Psoriasis
- Ankylosing Spondylitis
- By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles:
- AbbVie Inc.
- Johnson & Johnson
- Amgen Inc.
- Hoffmann-La Roche Ltd
- Pfizer Inc.
- Novartis International AG
- Bristol-Myers Squibb Company
- Merck & Co., Inc.
- AstraZeneca PLC
- Sanofi
- GlaxoSmithKline plc
- UCB S.A.
- Eli Lilly and Company
- Gilead Sciences Inc.
- Celgene Corporation
- Biogen Inc.
- Regeneron Pharmaceuticals Inc.
- Teva Pharmaceutical Industries Ltd.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Drug Class
- Market Snapshot, By Disease Indication
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Acquisitions and Partnerships Scenario
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Immunology Market - Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the Market
5. Global Immunology Market, By Drug Class, 2020 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
- Monoclonal Antibody (mAb)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Fusion Proteins
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Immunosuppressants
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Polyclonal Antibody (pAb)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Immunology Market, By Disease Indication, 2020 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
- Rheumatoid Arthritis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Psoriatic Arthritis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Plaque Psoriasis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Ankylosing Spondylitis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Inflammatory Bowel Disease
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Prophylaxis of Organ Rejection
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Immunology Market, By Distribution Channel, 2020 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
- Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Immunology Market, By Region, 2020 - 2032, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2032
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- Company Profiles
- AbbVie Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Amgen Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- F. Hoffmann-La Roche Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Novartis International AG
- Bristol-Myers Squibb Company
- Merck & Co., Inc.
- AstraZeneca PLC
- Sanofi
- GlaxoSmithKline plc
- UCB S.A.
- Eli Lilly and Company
- Gilead Sciences Inc.
- Celgene Corporation
- Biogen Inc.
- Regeneron Pharmaceuticals Inc.
- Teva Pharmaceutical Industries Ltd.
- AbbVie Inc.
10. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. References and Research Methodology
- References
- Research Methodology
- About Us and Sales Contact
